Gastrointestinal Endoscopy
Volume 61, Issue 7 , Pages 795-801 , June 2005

Association of eosinophilic inflammation with esophageal food impaction in adults

Received 28 September 2004 ,Accepted 31 January 2005.

References 

  1. Orenstein SR, Shalaby TM, DiLorenzo C, Putnam PE, Sigurdsson L, Kocoshis SA. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol. 2000;95:1422–1430
  2. Walsh S, Antonioli D, Goldman H, Fox V, Bousvaros A, Leichtner A, et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol. 1999;23:390–396
  3. Liacouras C. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr. 2003;37:S23–S28
  4. Straumann ASH, Grize L, Bucher KA, Beglinger C, Simon H. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669
  5. Potter JW, Saeian K, Staff D, Massey BT, Komorowski RA, Shaker R, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc. 2004;59:355–361
  6. Croese J, Fairley SK, Masson JW, Chong AK, Whitaker DA, Kanowski PA, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003;58:516–522
  7. Teitelbaum J, Fox V, Twarog F, Nurko S, Antonioli D, Gleich G, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;1216–1225
  8. Longstreth GF, Longstreth KJ, Yao JF. Esophageal food impaction: epidemiology and therapy. A retrospective, observational study. Gastrointest Endosc. 2001;53:193–198
  9. Lao J, Bostwick HE, Berezin S, Halata MS, Newman LJ, Medow MS. Esophageal food impaction in children. Pediatr Emerg Care. 2003;19:402–407
  10. Lacy PD, Donnelly MJ, McGrath JP, Byrne PJ, Hennessy TP, Timon CV. Acute food bolus impaction: aetiology and management. J Laryngol Otol. 1997;111:1158–1161
  11. Vicente Y, Hernandez-Peredo G, Molina M, Prieto G, Tovar JA. Acute food bolus impaction without stricture in children with gastroesophageal reflux. J Pediatr Surg. 2001;36:1397–1400
  12. Liacouras C, Wenner W, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26:380–385
  13. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan J, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83:818–823
  14. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol. 2002;109:363–368
  15. Kelly K, Lazenby A, Rowe P, Yardley J, Perman J, Sampson H. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:1503–1512
  16. Arora AS, Perrault J, Smyrk TC. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc. 2003;78:830–835
  17. Attwood SE, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut. 2003;52:181–185
  18. Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol. 2004;113:115–119
  19. Wang HH, Mangano MM, Antonioli DA. Evaluation of T-lymphocytes in esophageal mucosal biopsies. Mod Pathol. 1994;7:55–58
  20. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108:954–961
  21. Hogan S, Mishra A, Brandt E, Royalty M, Pope S, Zimmerman N, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immun. 2001;2:353–360
  22. Furuta G, Ackerman S, Lu L, Williams R, Wershil B. Stem cell factor influences mast cell mediator release in response to eosinophil derived granule major basic protein. Blood. 1998;92:1055–1061
  23. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM. Human eosinophil major basic protein causes hyperactivity of respiratory smooth muscle. Am Rev Respir Dis. 1988;138:685–688
  24. Nurko S, Fortunato C, Antonioli A, Badizadegan K, Teitlebaum J, Furuta GT. Esophageal motility abnormalities in patients with allergic esophagitis. A study with prolonged esophageal pH/manometry. [abstract] J Pediatr Gastroenterol. 2001;33:A417
  25. Fox VL, Nurko S, Teitelbaum JE, Badizadegan K, Furuta GT. High-resolution EUS in children with eosinophilic “allergic” esophagitis. Gastrointest Endosc. 2003;57:30–36
  26. Noel RJ, Putnam PE, Collins MH, Assa'as AH, Guajardo JR, Jameson SC, et al. Clinical and immunopathological effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568–575

 See CME section; p. 872.Supported by National Institutes of Health grant DK062245.This work was presented, in part, at Digestive Diseases Week, May 19-23, 2002, San Francisco, California.

PII: S0016-5107(05)00313-5

Gastrointestinal Endoscopy
Volume 61, Issue 7 , Pages 795-801 , June 2005